AI Article Synopsis
- - Contraception is crucial for individuals with rheumatic and musculoskeletal diseases (RMDs) to prevent undesired pregnancies and improve reproductive health, yet many do not receive tailored counseling regarding their options.
- - The review highlights the availability of safe contraceptive methods for females with RMDs, emphasizing the need for specialized care for conditions like systemic lupus erythematosus and antiphospholipid syndrome due to their unique risks.
- - There is a lack of contraceptive options for male patients, and while guidelines for adolescents with RMDs can follow those for adults, additional focus on protection against STIs is necessary. Future studies should explore how contraception affects RMD activity and associated side effects.
Article Abstract
Contraception can help individuals with rheumatic and musculoskeletal diseases (RMDs) to avoid undesired pregnancies and improve reproductive outcomes. Despite the importance of contraception in the care of females with RMDs, evidence suggests that many of these individuals do not receive consistent or disease-specific counseling regarding contraceptive options. This includes female patients receiving teratogenic prescriptions as part of the management of their RMDs, or who have severe disease activity that might culminate in adverse pregnancy and perinatal outcomes. Contraceptive counseling can help females with RMDs who wish to prevent pregnancy to select a contraceptive method that is best for them.We conducted a narrative review of the primary literature addressing reversible, prescription-based contraception for females with RMDs, framed by published guidelines on contraceptive safety. Many safe and effective contraceptive options are available for females with RMDs. Special considerations must be given to individuals with systemic lupus erythematosus, whose disease activity may be exacerbated by exogenous estrogen. Females with positive antiphospholipid antibodies should avoid estrogen-containing contraception due to an unacceptable risk of thrombosis and should conditionally avoid depot medroxyprogesterone acetate, which appears to have a prothrombotic signature. Limited contraceptive options are available to male patients. Contraceptive care for adolescents with RMDs can be extrapolated from guidelines written for adult patients, with the additional consideration of barrier protection for individuals at risk for sexually transmitted infections. Future research is needed to assess the effects of contraception use on rheumatic disease activity and side effects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462883 | PMC |
| http://dx.doi.org/10.1097/RHU.0000000000002124 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perceived mistreatment in patients with rheumatic diseases: The impact of the underlying diagnosis.
PLoS One
January 2025
Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Background: Mistreatment is a complex problem that impacts people's quality of life, morbidity, and mortality. In aged people, it has been associated with female sex, poor general health, depression, functional and cognitive decline, and increased dependence levels, all of which are well-recognized characteristics of patients with rheumatic diseases (RMDs). The objective was to describe the mistreatment phenomenon in Mexican patients with RMDs.
View Article and Find Full Text PDFPattern of Rheumatic Diseases in a New Rheumatology Clinic in Southwestern Nigeria: A Descriptive Study.
West Afr J Med
August 2024
Department of Medicine, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. Email: Tel: 08063241116.
Background/objective: Rheumatic diseases (RMDs) are among the leading health burdens and causes of disability globally. Interestingly, they are on the rise due to the increasingly ageing population. Inflammatory RMDs are not left behind in the rise, especially in Africa, where they were thought to be rare as there has been increasing reportage of these diseases in recent years.
View Article and Find Full Text PDFDisease disclosure in the workplace in people living with rheumatic diseases: an exploratory study.
Reumatismo
October 2024
Psychology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia.
Article Synopsis
- - The study focused on the disclosure of rheumatic musculoskeletal diseases (RMDs) in the workplace, highlighting that these conditions can lead to frequent absenteeism and productivity loss, but not much is known about how patients choose to disclose their conditions.
- - Conducted through an online survey in Italy, the research found that 81.2% of working patients with RMDs disclosed their condition, and identified significant predictors of disclosure such as the visibility of the disease, type of work, general disclosure behaviors, and family support.
- - Results indicated that patients with psoriatic arthritis were more likely to disclose their condition, while those with fibromyalgia were less likely, and overall, shorter disease duration correlated with higher disclosure rates
Contraceptive Care in the Rheumatic Diseases: A Review.
J Clin Rheumatol
October 2024
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
Article Synopsis
- - Contraception is crucial for individuals with rheumatic and musculoskeletal diseases (RMDs) to prevent undesired pregnancies and improve reproductive health, yet many do not receive tailored counseling regarding their options.
- - The review highlights the availability of safe contraceptive methods for females with RMDs, emphasizing the need for specialized care for conditions like systemic lupus erythematosus and antiphospholipid syndrome due to their unique risks.
- - There is a lack of contraceptive options for male patients, and while guidelines for adolescents with RMDs can follow those for adults, additional focus on protection against STIs is necessary. Future studies should explore how contraception affects RMD activity and associated side effects.
Prevalence of rheumatic and musculoskeletal diseases (RMDs) in nursing home residents: a systematic literature review.
Eur Geriatr Med
October 2024
Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Article Synopsis
- This systematic literature review aimed to estimate how common rheumatic and musculoskeletal diseases (RMDs) are and how their symptoms are documented in nursing home residents aged 60 and older.
- After reviewing 6,900 records, 53 studies were included, showing a wide range in the prevalence of musculoskeletal pain (0.9% to 77.0%) and various RMDs (0.6% to 67.5%) among residents.
- The findings highlighted significant variability in how symptoms of RMDs are documented, suggesting that a standardized classification system could improve the identification of these conditions in nursing homes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!